跳至主要内容
临床试验/CTRI/2021/05/033634
CTRI/2021/05/033634尚未招募未知

Efficacy, Safety and Cost-effectiveness of Teneligliptin versus Glimepiride in uncontrolled Type 2 diabetes mellitus on metformin in a tertiary care hospital - A Randomized Controlled Open Labeled Comparative Study.

Dr V Gayathri0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.AGE between 30 to 60 years.
  • 2.Both male and female.
  • 3.Clinically diagnosed with Type2DM.
  • 4.Poor glycemic control by Metformin monotherapy with HbA1c > 7.5

排除标准

  • 1.Type 1 diabetes mellitus.
  • 2.Patients already on treatment with two or more Oral Hypoglycemic Agents.
  • 3.Pregnancy and Lactation.
  • 4.History of Alcohol intake and smoking.
  • 5.History of renal and hepatic disorders.
  • 6.Allergy to Teneligliptin and Glimepiride.

研究者

发起方
Dr V Gayathri

相似试验